Teams that have completed an EU launch for a phosphatidylserine product often assume the British market is the same file with a different address on the pack. It is not. Since the end of the transition period, Great Britain — England, Scotland and Wales — has operated its own food law, its own register of authorised novel foods and its own register of permitted nutrition and health claims, while Northern Ireland continues to apply EU food law for goods on its market. A single label and file cannot serve both without deliberate work.
The failure mode is predictable. A brand finalises artwork using its EU declarations, orders packaging, agrees a launch window with a UK distributor, and then learns that the ingredient's novel food status must be confirmed against the GB list, that the claim wording it used is not on the GB register, or that the food business operator address on the pack does not satisfy GB requirements. The reprint and delay cost more than the compliance work.
!Regulatory affairs specialist reviewing a UK food supplement compliance file with artwork proofs and declaration documents on a desk For the specification detail behind these documents, see our quality and R&D overview, including test methods and release criteria.
Great Britain and Northern Ireland Are Two Regimes
Start with geography, because it determines the rulebook. Great Britain comprises England, Scotland and Wales and applies GB food law, administered by the Food Standards Agency and the relevant devolved authorities. Northern Ireland applies EU food law for food placed on its market. If your launch covers the whole UK, you are running two compliance tracks, not one, and the pack may legitimately differ between them.
For a phosphatidylserine ingredient or finished product this affects the novel food list you check against, the claims register you draw on, and the operator address on the label. Launching in GB first and treating Northern Ireland separately is a legitimate commercial choice — but it should be a choice, not an accident of who printed the cartons.
Novel Food Status: Check the GB List, Not the EU Authorisation
Phospholipids from soybean were authorised as a novel food ingredient in the EU in the early 2000s, and soybean-derived phosphatidylserine sits within that family of authorisations. Great Britain carried over a list of novel foods authorised and on the market before the end of the transition period, and that carried-over list governs a GB placement. It is published and maintained by the FSA, and it is not automatically updated when the EU amends its own list.
Two consequences follow. First, confirm the specific entry covering your ingredient — source material, specification and any conditions of use — on the current GB list, and keep dated evidence of the check in your compliance file. Second, if your PS is a form, a source or a concentration authorised in the EU after the transition period, or if you cannot find a matching GB entry, do not assume mutual recognition. Novel food authorisation is a market-by-market permission, and the GB route has its own application process and timetable, measured in months.
The same discipline applies to the specification. If your supplier's dossier was built around one source material and you later switch to another, the authorisation you relied on may no longer describe the material you are buying, so sourcing changes should trigger a regulatory review and not only a specification amendment.
Supplement Composition and Labelling in Great Britain
Food supplements in Great Britain are regulated under retained food supplements regulations that operate separately for England, Scotland and Wales. They follow much of the pre-exit framework: notification before placing on the market, compositional requirements, and mandatory labelling and nutrition declaration rules that mirror EU food information law without being administered by the EU.
Three items most often force a reprint. The first is the food business operator address: an EU-based address alone does not satisfy the GB requirement, and the pack needs an operator or importer established in Great Britain named with contact details. If you import PS into GB and sell on without a GB-established operator, close that gap before printing. The second is the mandatory food information set, which should be checked as a whole rather than carried over. The third is the nutrition declaration format where PS is presented as a nutrient content. Keep the notification evidence too: separate obligations can apply to GB and to Northern Ireland, and a filing made for an EU market does not discharge either.
Health Claims: A Separate Register with Its Own History
Health claims in Great Britain are managed through a GB register of authorised nutrition and health claims rather than the EU register. The GB register preserves the claims authorised at the point of exit, but the two registers have since diverged: claims authorised in the EU since are not automatically available in GB, and the assessment route for new claims differs.
For a phosphatidylserine product this matters most for claims that go beyond composition — the cognitive function, stress and memory claims brands like to place on pack. Two rules apply regardless of register. A claim about a nutrient must satisfy the conditions of use attached to that entry. And the food must satisfy the conditions for the claim, which typically include a defined significant amount of the nutrient in the product as consumed. If your PS dose per serving does not meet those conditions, the claim is not available even though the wording appears on the register. Check the entry, the conditions and your dose — in that order, before artwork goes to print.
Documents to Re-Request and the Launch Sequence
A supplier documentation pack built for an EU filing usually needs reissue rather than reuse. Ask for a fresh specification confirming source material, PS content basis and assay method, cross-referenced to the authorisation you rely on. Ask for an allergen and composition declaration covering the soy origin position and any GB-specific wording, and for a signed, dated statement of the ingredient's regulatory status naming the GB list entry you identified. Ask for certificates — GMP, food safety, organic, halal, kosher — with validity dates in force, because a certificate that lapsed during an EU filing is not evidence for a GB launch, and for CoAs representative of current production with the laboratory's accreditation stated.
Market-neutral declarations are worth requesting explicitly, since one document set serving both the EU and GB files saves a revision cycle on every future change. Then run the launch in order: confirm the GB novel food position with dated evidence, confirm the claims and the dose conditions, design the label around a GB-established operator, complete notification before placing the product on the market, reissue supplier documents against the GB file, and only then commission artwork. If Northern Ireland is in scope, run the EU track in parallel from the start rather than retrofitting it later.
FAQ
Q: Can I use the same phosphatidylserine label in Great Britain and the EU?
A: Not automatically. Permitted health claims come from different registers, novel food checks are made against different lists, and the operator address requirement differs. Some packs can be harmonised with careful design, but that should be tested against both rulebooks before printing.
Q: Is phosphatidylserine a novel food in Great Britain?
A: Phospholipids from soybean were authorised as a novel food ingredient in the EU in the early 2000s, and Great Britain carried over a list of novel foods authorised and on the market at the end of the transition period. Confirm the specific entry covering your ingredient and its conditions of use on the current GB list maintained by the FSA, and keep dated evidence of that check.
Q: What address must appear on a supplement label in Great Britain?
A: A food business operator established in Great Britain — or, where relevant, an importer established in Great Britain — must be named with contact details on the pack. An EU-based operator address alone does not satisfy that requirement, and this is the most common cause of artwork rework on market entry.
Q: Do EU health claim authorisations for phosphatidylserine carry over to Great Britain?
A: The GB register preserves claims authorised at the point of exit, but the registers have diverged since. Check the claim wording on the GB register directly, then check the conditions of use attached to that entry against your product's PS content per serving; both must be satisfied.
Q: Do I need to re-notify my product for Great Britain?
A: Food supplement notification obligations operate in Great Britain and separately for Northern Ireland, and a notification filed for an EU market does not discharge either. Confirm the current requirement for the relevant GB nation with the local authority or your regulatory adviser.
Conclusion
A Great Britain launch for a phosphatidylserine product is not a relabelled EU launch. It is a separate compliance file built against a separate novel food list, a separate claims register and a separate labelling requirement — with Northern Ireland running on EU rules alongside it. The work is finite and predictable: check the GB novel food entry for your exact ingredient, confirm the claims and the dose conditions they impose, design the pack around a GB-established operator, complete notification, and ask your supplier to reissue documents against the GB file rather than recycle EU versions. Done in that order it costs a few weeks; done after printing it costs a reprint and a delay. When you are ready to move from checklist to quotation, contact our team with the grade, source and document set described above.
Sources
- UK Food Standards Agency — Novel foods guidance and the authorised novel food list: https://www.food.gov.uk/business-guidance/novel-foods
- UK Food Standards Agency — Food supplements guidance: https://www.food.gov.uk/business-guidance/food-supplements
- UK Government — Great Britain nutrition and health claims register: https://www.gov.uk/government/publications/great-britain-nutrition-and-health-claims-register
- UK Legislation — Food Supplements (England) Regulations 2003: https://www.legislation.gov.uk/uksi/2003/1387/contents
- European Union — Regulation (EU) 2015/2283 on novel foods: https://eur-lex.europa.eu/eli/reg/2015/2283/oj
Buyer fit
Who this guide is for
This guide is written for the buyer profiles below. Open your profile for the matching grades, documents and next steps, or tell us your requirements directly.
Recommended next steps
- Review the Phosphatidylserine product page.
- Compare Soy PS and Sunflower PS.
- Check manufacturing proof and Quality & R&D.
Contact sales for product documents
Share source preference, application, country, and annual quantity.
Contact Sales
